Literature DB >> 352259

Human leukocyte interferon in the treatment of varicella in children with cancer: a preliminary controlled trial.

A M Arvin, S Feldman, T C Merigan.   

Abstract

Eighteen patients who developed varicella while being treated for malignancy received human leukocyte interferon in a randomized double-blind placebo-controlled trial. Complications of varicella occurred in six of nine placebo recipients, but in only two of nine interferon recipients. Interferon was tolerated without significant side effects.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 352259      PMCID: PMC352295          DOI: 10.1128/AAC.13.4.605

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  A COMPLEMENT-FIXING ANTIGEN FOR VARICELLA-ZOSTER DERIVED FROM INFECTED CULTURES OF HUMAN FETAL DIPLOID CELLS.

Authors:  N J SCHMIDT; E H LENNETTE; C W SHON; T T SHINOMOTO
Journal:  Proc Soc Exp Biol Med       Date:  1964-05

2.  Zoster immune globulin. A further assessment.

Authors:  A A Gershon; S Steinberg; P A Brunell
Journal:  N Engl J Med       Date:  1974-01-31       Impact factor: 91.245

3.  Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study.

Authors:  R J Whitley; L T Ch'ien; R Dolin; G J Galasso; C A Alford
Journal:  N Engl J Med       Date:  1976-05-27       Impact factor: 91.245

4.  Varicella in children with cancer: Seventy-seven cases.

Authors:  S Feldman; W T Hughes; C B Daniel
Journal:  Pediatrics       Date:  1975-09       Impact factor: 7.124

5.  Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis.

Authors:  H B Greenberg; R B Pollard; L I Lutwick; P B Gregory; W S Robinson; T C Merigan
Journal:  N Engl J Med       Date:  1976-09-02       Impact factor: 91.245

  5 in total
  16 in total

Review 1.  Clinical uses of interferons.

Authors:  Robert M Friedman
Journal:  Br J Clin Pharmacol       Date:  2007-12-07       Impact factor: 4.335

2.  Advances in antiviral chemotherapy.

Authors:  R A Buchanan
Journal:  Can Med Assoc J       Date:  1979-01-06       Impact factor: 8.262

Review 3.  The interferon system as a basis for antiviral therapy or prophylaxis.

Authors:  A Billiau
Journal:  Antiviral Res       Date:  1985       Impact factor: 5.970

Review 4.  Interferon: therapeutic fact or fiction for the '80s?

Authors:  G M Scott; D A Tyrrell
Journal:  Br Med J       Date:  1980-06-28

5.  Examination of parameters affecting human interferon production with microcarrier-grown fibroblast cells.

Authors:  D J Giard; R J Fleischaker
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

Review 6.  Antiviral agents: an update--Part 2.

Authors:  S Bogger-Goren; P L Ogra
Journal:  Indian J Pediatr       Date:  1980 Nov-Dec       Impact factor: 1.967

Review 7.  Interferon therapy: pharmacokinetic and pharmacological aspects.

Authors:  A Billiau
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

Review 8.  Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.

Authors:  R B Pollard
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

Review 9.  Advances in interferon research - Medical Staff Conference.

Authors:  A A Creasey; T C Merigan
Journal:  West J Med       Date:  1982-03

10.  Treatment of hepatitis C infections with interferon: a historical perspective.

Authors:  Robert M Friedman; Sara Contente
Journal:  Hepat Res Treat       Date:  2010-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.